Italia markets closed
FTSE MIB
33.746,66 -549,65 (-1,60%) Dow Jones
37.903,29 +87,37 (+0,23%) Nasdaq
15.605,48 -52,34 (-0,33%) Nikkei 225
38.274,05 -131,61 (-0,34%) Petrolio
79,17 -2,76 (-3,37%) Bitcoin EUR
53.489,92 -2.385,74 (-4,27%)
DaVita Inc. (DVA)
NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 139,01 |
| Aperto | 138,11 |
| Denaro | 139,80 x 1000 |
| Lettera | 139,90 x 800 |
| Min-Max giorno | 136,35 - 140,75 |
| Intervallo di 52 settimane | 71,51 - 141,54 |
| Volume | |
| Media Volume | 816.354 |
| Capitalizzazione | 12,256B |
| Beta (5 anni mensile) | 1,05 |
| Rapporto PE (ttm) | 18,83 |
| EPS (ttm) | 7,42 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 132,00 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.